Literature DB >> 18592353

Microfabricated particles for engineered drug therapies: elucidation into the mechanisms of cellular internalization of PRINT particles.

Stephanie E A Gratton1, Mary E Napier, Patricia A Ropp, Shaomin Tian, Joseph M DeSimone.   

Abstract

PURPOSE: To investigate the cellular internalization pathways of shape- and size-specific particles as a function of zeta potential in different cell types.
METHODS: A top-down particle fabrication technique called PRINT was utilized to fabricate monodisperse 1 microm cylindrical particles. Cellular internalization of these PRINT particles was monitored using confocal microscopy, flow cytometry, and transmission electron microscopy. The endocytic pathway used by 1 microm cationic PRINT particles was evaluated using different inhibitory strategies. Cytotoxicity assays were used to determine the toxicity of both cationic and anionic PRINT particles in multiple cell types.
RESULTS: Particle internalization was confirmed using confocal microscopy, flow cytometry and transmission electron microscopy. The mechanism of internalization of positively charged PRINT particles was found to be predominantly clathrin-mediated endocytosis and macropinocytosis with very few particles utilizing a caveolae-mediated endocytic pathway. The exposed charge on the surface of the particles had a significant effect on the rate of endocytosis in all cell types tested, except for the macrophage cells. No significant cytotoxicity was observed for all PRINT particles used in the present study.
CONCLUSIONS: Cylindrical 1 microm PRINT particles were readily internalized into HeLa, NIH 3T3, OVCAR-3, MCF-7, and RAW 264.7 cells. Particles with a positive zeta potential exhibited an enhanced rate of endocytosis compared to negatively charged particles with identical sizes and shapes. It was found that PRINT particles with a positive zeta potential were endocytosed into HeLa cells using predominantely clathrin-mediated and macropinocytotic pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18592353      PMCID: PMC2593117          DOI: 10.1007/s11095-008-9654-8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  30 in total

1.  Polylysine-based transfection systems utilizing receptor-mediated delivery.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1998-03-02       Impact factor: 15.470

Review 2.  Dendrimers in biomedical applications--reflections on the field.

Authors:  Sönke Svenson; Donald A Tomalia
Journal:  Adv Drug Deliv Rev       Date:  2005-11-21       Impact factor: 15.470

3.  Quantitating intracellular transport of polyplexes by spatio-temporal image correlation spectroscopy.

Authors:  Rajan P Kulkarni; David D Wu; Mark E Davis; Scott E Fraser
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-16       Impact factor: 11.205

4.  Dynasore, a cell-permeable inhibitor of dynamin.

Authors:  Eric Macia; Marcelo Ehrlich; Ramiro Massol; Emmanuel Boucrot; Christian Brunner; Tomas Kirchhausen
Journal:  Dev Cell       Date:  2006-06       Impact factor: 12.270

Review 5.  Imparting size, shape, and composition control of materials for nanomedicine.

Authors:  Larken E Euliss; Julie A DuPont; Stephanie Gratton; Joseph DeSimone
Journal:  Chem Soc Rev       Date:  2006-09-20       Impact factor: 54.564

Review 6.  Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers.

Authors:  Julie A Champion; Yogesh K Katare; Samir Mitragotri
Journal:  J Control Release       Date:  2007-04-11       Impact factor: 9.776

7.  Evaluation of aminoalkylmethacrylate nanoparticles as colloidal drug carrier systems. Part I: Synthesis of monomers, dependence of the physical properties on the polymerization methods.

Authors:  H P Zobel; A Zimmer; S Atmaca-Abdel Aziz; M Gilbert; D Werner; C R Noe; J Kreuter; F Stieneker
Journal:  Eur J Pharm Biopharm       Date:  1999-05       Impact factor: 5.571

8.  Self-assembled poly(butadiene)-b-poly(ethylene oxide) polymersomes as paclitaxel carriers.

Authors:  Shuliang Li; Belinda Byrne; Joellen Welsh; Andre F Palmer
Journal:  Biotechnol Prog       Date:  2007 Jan-Feb

9.  Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of PRINT nanoparticles.

Authors:  Stephanie E A Gratton; Patrick D Pohlhaus; Jin Lee; Ji Guo; Moo J Cho; Joseph M Desimone
Journal:  J Control Release       Date:  2007-06-02       Impact factor: 9.776

10.  Synthetic biocompatible cyclodextrin-based constructs for local gene delivery to improve cutaneous wound healing.

Authors:  Nathalie C Bellocq; David W Kang; Xuehui Wang; Gregory S Jensen; Suzie H Pun; Thomas Schluep; Monica L Zepeda; Mark E Davis
Journal:  Bioconjug Chem       Date:  2004 Nov-Dec       Impact factor: 4.774

View more
  31 in total

1.  Structure-property relationship in cytotoxicity and cell uptake of poly(2-oxazoline) amphiphiles.

Authors:  Robert Luxenhofer; Gaurav Sahay; Anita Schulz; Daria Alakhova; Tatiana K Bronich; Rainer Jordan; Alexander V Kabanov
Journal:  J Control Release       Date:  2011-04-13       Impact factor: 9.776

2.  Hydrogel microparticles from lithographic processes: novel materials for fundamental and applied colloid science.

Authors:  Matthew E Helgeson; Stephen C Chapin; Patrick S Doyle
Journal:  Curr Opin Colloid Interface Sci       Date:  2011-04-01       Impact factor: 6.448

Review 3.  Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles.

Authors:  José M Morachis; Enas A Mahmoud; Adah Almutairi
Journal:  Pharmacol Rev       Date:  2012-04-27       Impact factor: 25.468

Review 4.  Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers.

Authors:  Mary Caldorera-Moore; Nathalie Guimard; Li Shi; Krishnendu Roy
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

Review 5.  Strategies in the design of nanoparticles for therapeutic applications.

Authors:  Robby A Petros; Joseph M DeSimone
Journal:  Nat Rev Drug Discov       Date:  2010-07-09       Impact factor: 84.694

Review 6.  Nanocarriers' entry into the cell: relevance to drug delivery.

Authors:  Hervé Hillaireau; Patrick Couvreur
Journal:  Cell Mol Life Sci       Date:  2009-06-05       Impact factor: 9.261

Review 7.  Conscripts of the infinite armada: systemic cancer therapy using nanomaterials.

Authors:  David A Scheinberg; Carlos H Villa; Freddy E Escorcia; Michael R McDevitt
Journal:  Nat Rev Clin Oncol       Date:  2010-03-30       Impact factor: 66.675

8.  Targeted PRINT Hydrogels: The Role of Nanoparticle Size and Ligand Density on Cell Association, Biodistribution, and Tumor Accumulation.

Authors:  Kevin G Reuter; Jillian L Perry; Dongwook Kim; J Christopher Luft; Rihe Liu; Joseph M DeSimone
Journal:  Nano Lett       Date:  2015-09-30       Impact factor: 11.189

9.  Scalable, shape-specific, top-down fabrication methods for the synthesis of engineered colloidal particles.

Authors:  Timothy J Merkel; Kevin P Herlihy; Janine Nunes; Ryan M Orgel; Jason P Rolland; Joseph M DeSimone
Journal:  Langmuir       Date:  2010-08-17       Impact factor: 3.882

Review 10.  Self-assembled lipid nanomedicines for siRNA tumor targeting.

Authors:  Yu-Cheng Tseng; Leaf Huang
Journal:  J Biomed Nanotechnol       Date:  2009-08       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.